Prince Harry claims to have been "singled out" for "inferior treatment" amid the latest round of legal action over his security arrangements. The 40-year-old royal appeared at the Court of Appeal in ...

Prince Harry's legal team has argued that he was "singled out" for inferior treatment" when his security was downgraded upon his decision to quit senior royal life. The claim was made during the first ...

"In fact, in his submission, it means that he has been singled out for different, unjustified and inferior treatment." A lawyer for the government said Harry's argument in the lower court was ...

Prince Harry has said he was 'singled out for inferior treatment' when his security was downgraded following his decision to step back from royal duties, a court heard today. The Duke of Sussex is ...

unjustified and inferior treatment" But the barrister representing the government tells the court the decision that Harry's UK security would be considered on a case-by-case basis was rightly ...

Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...

The Duke of Sussex has been “singled out for different, unjustified and inferior treatment”, the Court of Appeal has heard in the royal’s challenge over his level of security in the UK.

“He has been singled out for different, unjustified, and inferior treatment. “Not only does the bespoke process not involve the RMB, it also involved Ravec considering the reason why ...

Nasal sprays are often the go-to remedy for relief from a blocked nose or persistent allergies. Their quick, targeted action makes them a convenient option for many. But what happens if this seemingly ...

nasal septum, inferior nasal conchae; and (5) evidence of periodontal inflammation and alveolar recession in the posterior dentition. As a syndrome, these manifestations of rhinomaxillary disease ...

BioN­Tech has high­ly en­cour­ag­ing sur­vival da­ta for its bis­pe­cif­ic an­ti­body com­bin­ing check­point block­ade with VEGF-A in­hi­bi­tion as a first-line treat­ment for ...